Consensus estimates: Colruyt is too expensive

It seems Colruyt 's stock price too high now. Most of the analysts say Colruyt is now overpriced at this level. The recommendations spread over: 8 times sell, 3 times hold and no buys. The average of the target prices for the stock equals 39,36 euros. This is around 12 percent less than the current price of 44,79 euros.

Hardly any diversity estimates Colruyt

For this year Colruyt 's revenue will be around 9,03 billion euros. This is according to the average of the analysts' estimates. This is slightly lower than 2016's revenue of 9,49 billion euros.

Historical revenues and results Colruyt plus estimates 2018

The analysts expect for 2018 a net profit of 342 million euros. Most of the analysts anticipate on a profit per share of 2,38 euros. The price/earnings-ratio therefore equals 18,82.

Analysts expect a dividend of 1,06 euros per share. The dividend yield is then 2,37 percent. The average dividend yield of the food & drug retailers equals a poor 1 percent.

Latest estimates around 39 euros

The most recent recommendations for the food & drug retailer are from ING, KBC Securities and Raymond James.

Based on the current number of shares Colruyt 's market capitalization equals 6,6 billion euros.

Historical stock prices Colruyt

At 10.04 the stock trades 0,02 percent lower at 44,79 euros.

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.